Eden Biologics, Inc. Announces the Completion of the Sale of CDMO Business Assets
To Eden Biologics Investors, Partners, Colleagues and Friends:
I would like to take this opportunity to inform our shareholders that our CDMO Business Unit has been acquired by Bora Pharmaceuticals Co., LTD. Bora, effective as of July 1, 2022.